Loading...
Sorafenib — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Sorafenib
2025-Q4
Comprehensive analysis of India’s sorafenib export trade — suppliers, buyers, prices, routes, and every shipment record.
79
Shipments
$520K
Trade Value
43
Suppliers
29
Buyers
35
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/sorafenib
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s sorafenib trade — 2025-Q4
KEY TAKEAWAY
Sorafenib 2025-Q4 exports total $520.1K across 35 countries, with TORRENT PHARMACEUTICALS LTD commanding 60.4% market share.
TOTAL SHIPMENTS
79
2025-Q4
EXPORT VALUE
$520.1K
FOB USD
TOTAL QUANTITY
133.9K
units shipped
INDIAN SUPPLIERS
43
unique exporters
GLOBAL BUYERS
29
unique importers
DESTINATIONS
35
countries
MEDIAN UNIT PRICE
$7.71
per unit
TOP-5 SHARE
90.7%
of total USD
BRANDED SHARE
67.1%
53 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
TORRENT PHARMACEUTICALS LTD is India's #1 Sorafenib exporter with $314.3K (60.4% market share).→ §5, Indian Supplier Rankings
2
Sorafenib reached 35 countries, with United States as the top destination ($276.3K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4227) — top 10 suppliers control 95.9% of exports.→ §5, Indian Supplier Rankings
4
93.1% of buyers (27 of 29) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (74.8%) across 3 dosage forms.→ §7, Price Benchmarks
6
35 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 TORRENT PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian sorafenib exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Sorafenib report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial sorafenib trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian sorafenib suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Sorafenib India trade report
Product scope
Sorafenib
All variants merged — branded and generic formulations of sorafenib
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
79
Every commercial sorafenib trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $338.0K, Nov $36.6K, Dec $145.6K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$338.0K
Oct USD
10 shipments
2
$36.6K
Nov USD
-89.2% MoM
3
$145.6K
Dec USD
+297.9% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 89.2% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $338K, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $520K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $301K dip in Nov, $109K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $338K | 10 shipments |
| Nov | $37K | 22 shipments |
| Dec | $146K | 47 shipments |
| Q4 Total | $520K | 79 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Afghanistan held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: TORRENT PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import sorafenib from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 53.1% of India’s 2025-Q4 sorafenib trade ($276.3K). Beyond the top 10 destinations, 35 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 15 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 35 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much sorafenib India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$167K
32.1% of trade
11 countries · 33 shipments
Europe
$50K
9.6% of trade
3 countries · 6 shipments
Americas
$279K
53.6% of trade
6 countries · 7 shipments
Africa
$25K
4.7% of trade
15 countries · 33 shipments
Fig 4.1 United States is the #1 corridor ($276K) — 30 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian sorafenib it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $276K | 1 | TORRENT PHARMACEUTICALS LTD | $276K | — | — | — | — |
| 2 | Nepal | $122K | 4 | INDCHEMIE HEALTH SPECIALITIES PVT LTD | $122K | MACLEODS PHARMACEUTICALS LTD | $55 | — | — |
| 3 | United Kingdom | $38K | 1 | TORRENT PHARMACEUTICALS LTD | $38K | — | — | — | — |
| 4 | Cambodia | $15K | 2 | FLORENCIA HEALTHCARE | $15K | — | — | — | — |
| 5 | Afghanistan | $14K | 4 | KERK | $9K | RESCUERS LIFE SCIENCES LTD | $5K | SARTAJ PHARMA PVT LTD | $59 |
| 6 | Moldova | $11K | 2 | KWALITY PHARMACEUTICALS LTD | $11K | — | — | — | — |
| 7 | United Arab Emirates | $9K | 12 | WESTCOAST PHARMACEUTICAL WORKS LTD | $8K | HUMANKIND PHARMA | $228 | MDS ENTERPRISES | $16 |
| 8 | Mauritius | $6K | 1 | THERDOSE PHARMA PVT LTD | $6K | — | — | — | — |
| 9 | Burkina Faso | $3K | 6 | SANSKRUTI PHARMA | $3K | SR FARMALIFE PVT LTD | $11 | — | — |
| 10 | Angola | $3K | 3 | ILMIC HEALTH CARE PVT LTD | $3K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 32.1% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
53.1%
#1 country share
United States alone
89.5%
Top 5 share
5 of 35 countries
98.5%
Top 15 share
Long tail of 20 countries = 1.5%
HHI 3455
Destination HHI
Highly concentrated
35
Countries served
Global pharma reach from India
15
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
43 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
TORRENT PHARMACEUTICALS LTD ($314.3K, 60.4% share) and INDCHEMIE HEALTH SPECIALITIES PVT LTD ($122.3K) together control 83.9% of India’s 2025-Q4 sorafenib trade. The top 5 suppliers hold 90.7%. 43 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian sorafenib suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 TORRENT PHARMACEUTICALS LTD leads by $192K over INDCHEMIE HEALTH SPECIALITIES PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: R.S. SURGIPHARM PVT is #18 by value but #5 by volume.
Fig 5.2 SANSKRUTI PHARMA also leads by shipment count (5) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: R.S. SURGIPHARM PVT moves from #5 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 43 sorafenib suppliers split into strategic segments
KEY TAKEAWAY
11 suppliers (25%) generate 96.5% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 TORRENT PHARMACEUTICALS LTD and INDCHEMIE HEALTH SPECIALITIES PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 96.5% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | 1 | 2 | $314K |
| 2 | INDCHEMIE HEALTH SPECIALITIES PVT LTD | 1 | 1 | $122K |
| 3 | FLORENCIA HEALTHCARE | 1 | 1 | $15K |
| 4 | KWALITY PHARMACEUTICALS LTD | 1 | 1 | $11K |
| 5 | KERK | 1 | 1 | $9K |
| 6 | WESTCOAST PHARMACEUTICAL WORKS LTD | 1 | 1 | $8K |
| 7 | THERDOSE PHARMA PVT LTD | 1 | 1 | $6K |
| 8 | RESCUERS LIFE SCIENCES LTD | 1 | 1 | $5K |
| 9 | SANSKRUTI PHARMA | 1 | 1 | $3K |
| 10 | ILMIC HEALTH CARE PVT LTD | 1 | 1 | $3K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the sorafenib manufacturing hubs
KEY TAKEAWAY
Ahmedabad. Gujarat and Daman together account for $399K of India’s 2025-Q4 sorafenib trade.
Fig 5.5 Ahmedabad. Gujarat (1 exporters, $276K) and Daman (1 exporters, $122K) are India’s sorafenib capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
90.7%
Top 5 share
5 of 43 suppliers
95.9%
Top 10 share
10 of 43 suppliers
96.5%
Top 25% share
11 suppliers = 96% USD
HHI 4227
Supplier HHI
Concentrated
43
Total suppliers
shipped Sorafenib in 2025-Q4
20+ cities
Indian hubs
Ahmedabad. Gujarat and Daman lead
§5.2 Coming next: 0 exporter deep-dive profiles
Each of the top 0 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
29 importers across 35 countries — who is buying Indian sorafenib and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 92.0% of total USD. 93% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian sorafenib. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 TORRENT PHARMA INC is the #1 importer at $276K (53.1%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
93%
Single-source
27 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
7%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source sorafenib from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Afghanistan 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MUBARAK HASHIMI LTD | KERK | $9K | $8.865 | Tablet |
| ETEMED MOSLEH LTD | RESCUERS LIFE SCIENC… | $5K | $2.500 | Tablet |
| SARTAJ ENTERPRISES LTD | SARTAJ PHARMA PVT LTD | $59.043 | $0.033 | Tablet |
Nepal 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BALMED PHARMA PVT LTD | INDCHEMIE HEALTH SPE… | $122K | $2.251 | Capsule |
| MEDINURA PVT LTD | MACLEODS PHARMACEUTI… | $55.126 | $0.110 | Tablet |
China 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DALIAN CHAOHONGSUPPLY … | JMB PHARMACEUTICALS … | $2K | $30.288 | Tablet |
| DALIAN SA | SHOBHA MEDICINE | $1K | $43.251 | Tablet |
United States 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TORRENT PHARMA INC | TORRENT PHARMACEUTIC… | $276K | $1K | Tablet |
United Kingdom 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TORRENT PHARMA (UK) LTD | TORRENT PHARMACEUTIC… | $38K | $190.037 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | TORRENT PHARMA INC | United States | $276K | $276K | Premium |
| 2 | BALMED PHARMA PVT LTD | Nepal | $122K | $41K | Premium |
| 3 | TORRENT PHARMA (UK) … | United Kingdom | $38K | $38K | Premium |
| 4 | MUBARAK HASHIMI LTD | Afghanistan | $9K | $9K | Budget |
| 5 | SOZAHEALTH LTD | Mauritius | $6K | $6K | Budget |
| 6 | DITA ESTFARM LLC | Moldova | $6K | $6K | Budget |
| 7 | ETEMED MOSLEH LTD | Afghanistan | $5K | $3K | Budget |
| 8 | EHSAN COMERCIO GERL … | Angola | $3K | $1K | Budget |
| 9 | NANG DAO | Laos | $3K | $3K | Budget |
| 10 | CENTRAIMED | Equatorial Guinea | $3K | $3K | Budget |
| 11 | MEDICUBA, S.A | Cuba | $2K | $2K | Budget |
| 12 | DALIAN CHAOHONGSUPPL… | China | $2K | $2K | Budget |
| 13 | DALIAN SA | China | $1K | $1K | Budget |
| 14 | OUMAR KONE | Mali | $564.465 | $564.000 | Budget |
| 15 | ATLAS TRADING COMPANY | Iraq | $322.889 | $323.000 | Budget |
| 16 | GOLD TREE PHARMACEUT… | Kenya | $299.003 | $299.000 | Budget |
| 17 | SOVEREIGN SPEED FRA … | Germany | $238.048 | $79.000 | Budget |
| 18 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $227.920 | $33.000 | Budget |
| 19 | R PHARMA | Malawi | $176.659 | $177.000 | Budget |
| 20 | FREIGHTER MADE LOGIS… | Ghana | $174.101 | $174.000 | Budget |
| 21 | AL-NOOR FOR DRUGS & … | Yemen | $134.219 | $134.000 | Budget |
| 22 | LATOYA SHONELL GOODI… | Guyana | $81.595 | $82.000 | Budget |
| 23 | SARTAJ ENTERPRISES LTD | Afghanistan | $59.043 | $59.000 | Budget |
| 24 | MEDINURA PVT LTD | Nepal | $55.126 | $55.000 | Budget |
| 25 | MOHAMED AHEMED MOHAMUD | Somalia | $4.600 | $5.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 TORRENT PHARMACEUTICALS LTD → TORRENT PHARMA INC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian sorafenib prices vary by supplier, country and dosage form
KEY TAKEAWAY
Sorafenib prices span 40105× ($0.033 → $1315.52). The coefficient of variation is 3.88. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.033 | Lowest observed unit price |
| P5 | $0.103 | 5th percentile |
| P25 | $1.00 | 25th percentile (Q1) |
| Median | $7.71 | 50th percentile (Q2) |
| P75 | $35.08 | 75th percentile (Q3) |
| P95 | $88.50 | 95th percentile |
| Max | $1.3K | Highest observed unit price |
| Mean | $40.22 | Arithmetic average |
| CV | 388% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 TORRENT PHARMACEUTICALS LTD prices at $752.78/unit vs market median $7.71.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. INDCHEMIE HEALTH SPECIALITIES Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. TORRENT PHARMACEUTICALS LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. KERK Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. KASO PHARMACEUTICALS Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | TORRENT PHARMACE… | United States | Tablet | 210 | $276K | $1K | Specialty / small-batch |
| Oct 2025 | TORRENT PHARMACE… | United Kingdom | Tablet | 200 | $38K | $190.04 | Specialty / small-batch |
| Oct 2025 | RUTVA MEDICARE | Zimbabwe | Tablet | 2 | $204.47 | $102.23 | Specialty / small-batch |
| Oct 2025 | RUTVA MEDICARE | Zimbabwe | — | 3 | $270.61 | $90.20 | Specialty / small-batch |
| Dec 2025 | MATOSHREE HEALTH… | Ethiopia | Tablet | 20 | $2K | $86.79 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Zimbabwe | Tablet | 3 | $239.59 | $79.86 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Zimbabwe | Tablet | 3 | $239.59 | $79.86 | Specialty / small-batch |
| Dec 2025 | KASO PHARMACEUTI… | Laos | Tablet | 40 | $3K | $75.54 | Specialty / small-batch |
| Oct 2025 | FLORENCIA HEALTH… | Cambodia | Tablet | 130 | $8K | $58.70 | Specialty / small-batch |
| Oct 2025 | FLORENCIA HEALTH… | Cambodia | Tablet | 130 | $8K | $58.70 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | SARTAJ PHARMA PV… | Afghanistan | Tablet | 2K | $59.04 | $0.033 | |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Tablet | 104 | $8.29 | $0.080 | Small sample / trial shipment |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Tablet | 96 | $7.65 | $0.080 | Small sample / trial shipment |
| Dec 2025 | BARAKAH BIOHEALT… | Tanzania | Tablet | 50 | $4.74 | $0.095 | Small sample / trial shipment |
| Dec 2025 | MACLEODS PHARMAC… | Nepal | Tablet | 500 | $55.13 | $0.110 | Small sample / trial shipment |
| Dec 2025 | VAMA LIFECARE PV… | Sri Lanka | Tablet | 1 | $0.144 | $0.144 | Small sample / trial shipment |
| Dec 2025 | VAMA LIFECARE PV… | Sri Lanka | Tablet | 9 | $1.29 | $0.144 | Small sample / trial shipment |
| Oct 2025 | HETERO LABS LTD | Brazil | — | 1 | $0.169 | $0.169 | Small sample / trial shipment |
| Oct 2025 | HETERO LABS LTD | Brazil | Tablet | 2 | $0.339 | $0.169 | Small sample / trial shipment |
| Nov 2025 | KWALITY PHARMACE… | Moldova | Tablet | 26K | $6K | $0.222 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship sorafenib, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Sorafenib leaves India through 9+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), RAXAUL, AHMEDABAD AIR) handle 96.2% of total USD. SEA moves 6% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $278K — top 9 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Norfolk is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 6% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$278K
53.4% of USD · 6.3% of ships
ROAD
$122K
23.5% of USD · 5.1% of ships
AIR
$95K
18.2% of USD · 82.3% of ships
ICD
$25K
4.9% of USD · 6.3% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → N. America ($276K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Germany is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 4111).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Germany (HHI 10,000) is the most concentrated — Kenya (HHI 4,111) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| TORRENT PHARMA INC | United States | TORRENT PHARMACE… | $276K | 1 | HIGH |
| BALMED PHARMA PVT LTD | Nepal | INDCHEMIE HEALTH… | $122K | 3 | HIGH |
| TORRENT PHARMA (UK) … | United Kingdom | TORRENT PHARMACE… | $38K | 1 | MEDIUM |
| MUBARAK HASHIMI LTD | Afghanistan | KERK | $9K | 1 | MEDIUM |
| SOZAHEALTH LTD | Mauritius | THERDOSE PHARMA … | $6K | 1 | MEDIUM |
| DITA ESTFARM LLC | Moldova | KWALITY PHARMACE… | $6K | 1 | MEDIUM |
| ETEMED MOSLEH LTD | Afghanistan | RESCUERS LIFE SC… | $5K | 2 | MEDIUM |
| EHSAN COMERCIO GERL … | Angola | ILMIC HEALTH CAR… | $3K | 3 | MEDIUM |
Conclusion: 27 buyers depend on exactly one Indian supplier, representing $478K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cambodia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Moldova | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mauritius | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Angola | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Laos | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| China | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Equatorial Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ethiopia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cameroon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Germany lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (1 suppliers) | This Q | HIGH |
| A6 | Enter Nepal (2 suppliers) | This Q | MED |
| A8 | Build Nepal distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 1 | $276K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Nepal | Asia | 2 | $122K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | United Kingdom | Other | 1 | $38K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Cambodia | Asia | 1 | $15K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Afghanistan | Asia | 3 | $14K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 6 | Moldova | Other | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | United Arab Emirates | Other | 3 | $9K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 8 | Mauritius | Africa | 1 | $6K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Burkina Faso | Africa | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Angola | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Laos | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | China | Asia | 2 | $3K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Equatorial Guinea | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Ethiopia | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Cameroon | Africa | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 79 2025-Q4 Sorafenib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/sorafenib
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 79 2025-Q4 sorafenib shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian sorafenib shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
79
across all regions
TOTAL USD
$520K
2025-Q4 FOB value
UNITS
133.9K
tablets, capsules, etc.
SUPPLIERS
43
Indian exporters
BUYERS
29
global importers
COUNTRIES
35
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $25K (4.7%), spanning 15 countries.
43 Indian suppliers shipped to 29 buyers across 35 countries — average shipment value $7K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
15 countries · 33 shipments · $25K · 19 Indian suppliers · 10 buyers
SHIPMENTS
33
USD
$25K
COUNTRIES
15
SUPPLIERS
19
BUYERS
10
HHI
1,407
competitive
Top 15 destination countries in Africa
1
Mauritius (26.3%)
$6K
2
Burkina Faso (14.0%)
$3K
3
Angola (13.4%)
$3K
4
Equatorial Guinea (11.2%)
$3K
5
Ethiopia (10.7%)
$3K
6
Cameroon (8.1%)
$2K
7
Kenya (6.7%)
$2K
8
Zimbabwe (3.9%)
$954.26
9
Mali (2.3%)
$567.77
10
Burundi (2.0%)
$490.00
11
Malawi (0.7%)
$176.66
12
Ghana (0.7%)
$174.10
13
Tanzania (0.0%)
$4.74
14
Somalia (0.0%)
$4.60
15
Cote d'Ivoire (0.0%)
$0.837
Top 19 Indian suppliers into Africa
1
THERDOSE PHARMA PVT LTD
$6K
2
SANSKRUTI PHARMA
$3K
3
ILMIC HEALTH CARE PVT LTD
$3K
4
PIRZE LIFECARE PVT LTD
$3K
5
MATOSHREE HEALTH CARE PVT LTD
$3K
6
NEOPHAR PHARMACEUTICALS PVT LTD
$2K
7
R.S. SURGIPHARM PVT LTD
$913.58
8
KHATU ENTERPRISES
$564.46
9
BRUCK PHARMA PVT LTD
$490.84
10
HEET HEALTHCARE PVT LTD
$479.18
11
RUTVA MEDICARE
$475.08
12
ASPIRA BIOHEALTH LLP
$429.51
13
ASPIDA LIFE SCIENCES PVT LTD
$299.00
14
MATHI ASSOCIATES
$176.66
15
BAKER & DAVIS PVT LTD
$174.10
16
SR FARMALIFE PVT LTD
$11.37
17
BARAKAH BIOHEALTH LLP
$4.74
18
M T MADON EXPORTS
$4.60
19
GENETEC LIFESCIENCES
$3.30
Top 8 Africa importers
1
SOZAHEALTH LTD · Mauritius
$6K
2
EHSAN COMERCIO GERL LDA · Angola
$3K
3
CENTRAIMED · Equatorial Guinea
$3K
4
OUMAR KONE · Mali
$564.46
5
GOLD TREE PHARMACEUTICALS LTD · Kenya
$299.00
6
R PHARMA · Malawi
$176.66
7
FREIGHTER MADE LOGISTICS LTD · Ghana
$174.10
8
MOHAMED AHEMED MOHAMUD · Somalia
$4.60
Top 2 dosage forms
1
Tablet
$24K
2
Unknown
$273.92
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $7K | $2K |
| Nov | 9 | $5K | $534.99 |
| Dec | 21 | $13K | $613.51 |
Shipment register · 33 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — THERDOSE PHARMA PVT LTD · 1 shipments · $6K | |||||||||||
| 1 | Oct 2025 | SOZAHEALTH LTD | Mauritius | Tablet | 833 | PCS | $7.77 | $6K | HYDERABAD AIR | MAURITIUS | AIR |
| SUPPLIER #2 — SANSKRUTI PHARMA · 5 shipments · $3K | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 15 | NOS | $54.43 | $816.45 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 3 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 15 | NOS | $52.33 | $785.02 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Tablet | 15 | NOS | $52.33 | $785.02 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 20 | NOS | $52.33 | $1K | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 6 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 7 | NOS | $0.911 | $6.38 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #3 — ILMIC HEALTH CARE PVT LTD · 3 shipments · $3K | |||||||||||
| 7 | Dec 2025 | EHSAN COMERCIO GERL LDA | Angola | Tablet | 293 | NOS | $7.71 | $2K | DELHI AIR | LUANDA - | AIR |
| 8 | Dec 2025 | EHSAN COMERCIO GERL LDA | Angola | Tablet | 33 | NOS | $7.71 | $254.34 | DELHI AIR | LUANDA - | AIR |
| 9 | Dec 2025 | EHSAN COMERCIO GERL LDA | Angola | Tablet | 100 | NOS | $7.93 | $792.62 | DELHI AIR | LUANDA - | AIR |
| SUPPLIER #4 — PIRZE LIFECARE PVT LTD · 1 shipments · $3K | |||||||||||
| 10 | Dec 2025 | CENTRAIMED | Equatorial Guinea | Tablet | 100 | NOS | $27.58 | $3K | AHMEDABAD AIR | MALABO | AIR |
| SUPPLIER #5 — MATOSHREE HEALTH CARE PVT LTD · 2 shipments · $3K | |||||||||||
| 11 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Tablet | 100 | NOS | $9.10 | $910.30 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 12 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Tablet | 20 | NOS | $86.79 | $2K | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #6 — NEOPHAR PHARMACEUTICALS PVT LTD · 2 shipments · $2K | |||||||||||
| 13 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 120 | NOS | $9.99 | $1K | DELHI AIR | DOUALA | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 80 | NOS | $9.99 | $799.35 | DELHI AIR | DOUALA | AIR |
| SUPPLIER #7 — R.S. SURGIPHARM PVT LTD · 3 shipments · $913.58 | |||||||||||
| 15 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 30 | NOS | $5.46 | $163.83 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 16 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 50 | PCS | $8.12 | $405.84 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 17 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 60 | PCS | $5.73 | $343.91 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #8 — KHATU ENTERPRISES · 1 shipments · $564.46 | |||||||||||
| 18 | Dec 2025 | OUMAR KONE | Mali | Tablet | 80 | NOS | $7.06 | $564.46 | MUMBAI AIR (SAHAR) | BAMAKO | AIR |
| SUPPLIER #9 — BRUCK PHARMA PVT LTD · 2 shipments · $490.84 | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Burundi | Tablet | 10 | NOS | $49.00 | $490.00 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Tablet | 1 | NOS | $0.837 | $0.837 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| SUPPLIER #10 — HEET HEALTHCARE PVT LTD · 2 shipments · $479.18 | |||||||||||
| 21 | Nov 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 3 | NOS | $79.86 | $239.59 | AHMEDABAD AIR | HARARE | AIR |
| 22 | Nov 2025 | UNKNOWN BUYER | Zimbabwe | Tablet | 3 | NOS | $79.86 | $239.59 | AHMEDABAD AIR | HARARE | AIR |
| SUPPLIER #11 — RUTVA MEDICARE · 2 shipments · $475.08 | |||||||||||
| 23 | Oct 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 2 | PCS | $102.23 | $204.47 | AHMEDABAD AIR | HARARE | AIR |
| 24 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 3 | PCS | $90.20 | $270.61 | AHMEDABAD AIR | HARARE | AIR | |
| SUPPLIER #12 — ASPIRA BIOHEALTH LLP · 1 shipments · $429.51 | |||||||||||
| 25 | Nov 2025 | UNLISTED BUYER | Kenya | Tablet | 40 | NOS | $10.74 | $429.51 | CHENNAI AIR | NAIROBI | AIR |
| SUPPLIER #13 — ASPIDA LIFE SCIENCES PVT LTD · 1 shipments · $299.00 | |||||||||||
| 26 | Nov 2025 | GOLD TREE PHARMACEUTICALS LTD | Kenya | Tablet | 20 | NOS | $14.95 | $299.00 | DELHI AIR | NAIROBI | AIR |
| SUPPLIER #14 — MATHI ASSOCIATES · 1 shipments · $176.66 | |||||||||||
| 27 | Dec 2025 | R PHARMA | Malawi | Tablet | 50 | NOS | $3.53 | $176.66 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #15 — BAKER & DAVIS PVT LTD · 1 shipments · $174.10 | |||||||||||
| 28 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 30 | NOS | $5.80 | $174.10 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #16 — SR FARMALIFE PVT LTD · 1 shipments · $11.37 | |||||||||||
| 29 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 20 | NOS | $0.569 | $11.37 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #17 — BARAKAH BIOHEALTH LLP · 2 shipments · $4.74 | |||||||||||
| 30 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 50 | NOS | $0.095 | $4.74 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 50 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #18 — M T MADON EXPORTS · 1 shipments · $4.60 | |||||||||||
| 32 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Tablet | 20 | NOS | $0.230 | $4.60 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #19 — GENETEC LIFESCIENCES · 1 shipments · $3.30 | |||||||||||
| 33 | Dec 2025 | UNLISTED BUYER | Mali | 10 | NOS | $0.330 | $3.30 | MUMBAI AIR (SAHAR) | BAMAKO | AIR | |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 33 shipments · $167K · 16 Indian suppliers · 13 buyers
SHIPMENTS
33
USD
$167K
COUNTRIES
11
SUPPLIERS
16
BUYERS
13
HHI
5,520
concentrated
Top 11 destination countries in Asia
1
Nepal (73.3%)
$122K
2
Cambodia (9.1%)
$15K
3
Afghanistan (8.3%)
$14K
4
United Arab Emirates (5.2%)
$9K
5
Laos (1.8%)
$3K
6
China (1.7%)
$3K
7
Turkey (0.3%)
$438.61
8
Iraq (0.2%)
$322.89
9
Yemen (0.1%)
$134.22
10
Lebanon (0.0%)
$5.62
11
Sri Lanka (0.0%)
$1.44
Top 16 Indian suppliers into Asia
1
INDCHEMIE HEALTH SPECIALITIES PVT LTD
$122K
2
FLORENCIA HEALTHCARE
$15K
3
KERK
$9K
4
WESTCOAST PHARMACEUTICAL WORKS LTD
$8K
5
RESCUERS LIFE SCIENCES LTD
$5K
6
KASO PHARMACEUTICALS
$3K
7
JMB PHARMACEUTICALS PVT LTD
$2K
8
SHOBHA MEDICINE
$1K
9
RMPL PHARMA LLP
$444.23
10
VATS INDUSTRIES PVT LTD
$322.89
11
HUMANKIND PHARMA
$227.92
12
J.A. UNITED EXPORTS PVT LTD
$134.22
13
SARTAJ PHARMA PVT LTD
$59.04
14
MACLEODS PHARMACEUTICALS LTD
$55.13
15
MDS ENTERPRISES
$15.95
16
VAMA LIFECARE PVT LTD
$1.44
Top 12 Asia importers
1
BALMED PHARMA PVT LTD · Nepal
$122K
2
MUBARAK HASHIMI LTD · Afghanistan
$9K
3
ETEMED MOSLEH LTD · Afghanistan
$5K
4
NANG DAO · Laos
$3K
5
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$2K
6
DALIAN SA · China
$1K
7
ATLAS TRADING COMPANY · Iraq
$322.89
8
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$227.92
9
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$134.22
10
SARTAJ ENTERPRISES LTD · Afghanistan
$59.04
11
MEDINURA PVT LTD · Nepal
$55.13
12
AS PER INVOICE SRI LANKA · Sri Lanka
$1.44
Top 3 dosage forms
1
Capsule
$122K
2
Tablet
$36K
3
Gel
$8K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $17K | $6K |
| Nov | 6 | $19K | $3K |
| Dec | 24 | $131K | $5K |
Shipment register · 33 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INDCHEMIE HEALTH SPECIALITIES PVT LTD · 3 shipments · $122K | |||||||||||
| 1 | Dec 2025 | BALMED PHARMA PVT LTD | Nepal | Capsule | 9.1K | NOS | $1.29 | $12K | RAXAUL | KATHMANDU | ROAD |
| 2 | Dec 2025 | BALMED PHARMA PVT LTD | Nepal | Capsule | 35.8K | NOS | $2.80 | $100K | RAXAUL | KATHMANDU | ROAD |
| 3 | Dec 2025 | BALMED PHARMA PVT LTD | Nepal | Capsule | 9.4K | NOS | $1.10 | $10K | RAXAUL | KATHMANDU | ROAD |
| SUPPLIER #2 — FLORENCIA HEALTHCARE · 2 shipments · $15K | |||||||||||
| 4 | Oct 2025 | UNLISTED BUYER | Cambodia | Tablet | 130 | PCS | $58.70 | $8K | TUGHLAKABAD ICD | SIHANOUKVILLE (KOMPO | ICD |
| 5 | Oct 2025 | UNLISTED BUYER | Cambodia | Tablet | 130 | PCS | $58.70 | $8K | TUGHLAKABAD ICD | SIHANOUKVILLE (KOMPO | ICD |
| SUPPLIER #3 — KERK · 1 shipments · $9K | |||||||||||
| 6 | Nov 2025 | MUBARAK HASHIMI LTD | Afghanistan | Tablet | 990 | NOS | $8.86 | $9K | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #4 — WESTCOAST PHARMACEUTICAL WORKS LTD · 1 shipments · $8K | |||||||||||
| 7 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Gel | 18.8K | NOS | $0.449 | $8K | AHMEDABAD AIR | DUBAI | AIR |
| SUPPLIER #5 — RESCUERS LIFE SCIENCES LTD · 2 shipments · $5K | |||||||||||
| 8 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 1.0K | NOS | $2.50 | $3K | DELHI AIR | KABUL | AIR |
| 9 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 1.0K | NOS | $2.50 | $3K | DELHI AIR | KABUL | AIR |
| SUPPLIER #6 — KASO PHARMACEUTICALS · 1 shipments · $3K | |||||||||||
| 10 | Dec 2025 | NANG DAO | Laos | Tablet | 40 | NOS | $75.54 | $3K | DELHI AIR | VIENTIANE | AIR |
| SUPPLIER #7 — JMB PHARMACEUTICALS PVT LTD · 3 shipments · $2K | |||||||||||
| 11 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Tablet | 50 | NOS | $30.29 | $2K | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 12 | Dec 2025 | UNLISTED BUYER | China | Tablet | 40 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 13 | Dec 2025 | UNLISTED BUYER | China | Tablet | 40 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| SUPPLIER #8 — SHOBHA MEDICINE · 1 shipments · $1K | |||||||||||
| 14 | Nov 2025 | DALIAN SA | China | Tablet | 30 | NOS | $43.25 | $1K | AHMEDABAD ICD | DALIAN | ICD |
| SUPPLIER #9 — RMPL PHARMA LLP · 2 shipments · $444.23 | |||||||||||
| 15 | Nov 2025 | UNLISTED BUYER | Turkey | Tablet | 20 | NOS | $21.93 | $438.61 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 20 | NOS | $0.281 | $5.62 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #10 — VATS INDUSTRIES PVT LTD · 1 shipments · $322.89 | |||||||||||
| 17 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 15 | NOS | $21.53 | $322.89 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #11 — HUMANKIND PHARMA · 7 shipments · $227.92 | |||||||||||
| 18 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $3.94 | $39.35 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 19 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $3.94 | $39.35 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 20 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $4.02 | $40.21 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 21 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $4.02 | $40.21 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 22 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 23 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $3.44 | $34.40 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 24 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 10 | NOS | $3.44 | $34.40 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #12 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $134.22 | |||||||||||
| 25 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Tablet | 20 | NOS | $6.71 | $134.22 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #13 — SARTAJ PHARMA PVT LTD · 1 shipments · $59.04 | |||||||||||
| 26 | Dec 2025 | SARTAJ ENTERPRISES LTD | Afghanistan | Tablet | 1.8K | NOS | $0.033 | $59.04 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #14 — MACLEODS PHARMACEUTICALS LTD · 1 shipments · $55.13 | |||||||||||
| 27 | Dec 2025 | MEDINURA PVT LTD | Nepal | Tablet | 500 | NOS | $0.110 | $55.13 | RAXAUL | BIRGUNJ | ROAD |
| SUPPLIER #15 — MDS ENTERPRISES · 4 shipments · $15.95 | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 104 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 96 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | SEA |
| 30 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 104 | NOS | $0.080 | $8.29 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 96 | NOS | $0.080 | $7.65 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #16 — VAMA LIFECARE PVT LTD · 2 shipments · $1.44 | |||||||||||
| 32 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Tablet | 9 | NOS | $0.144 | $1.29 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 33 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Tablet | 1 | NOS | $0.144 | $0.144 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 6 shipments · $50K · 3 Indian suppliers · 4 buyers
SHIPMENTS
6
USD
$50K
COUNTRIES
3
SUPPLIERS
3
BUYERS
4
HHI
6,377
concentrated
Top 3 destination countries in Europe
1
United Kingdom (76.4%)
$38K
2
Moldova (23.1%)
$11K
3
Germany (0.5%)
$238.05
Top 3 Indian suppliers into Europe
1
TORRENT PHARMACEUTICALS LTD
$38K
2
KWALITY PHARMACEUTICALS LTD
$11K
3
SACRED LEAVES PVT LTD
$238.05
Top 3 Europe importers
1
TORRENT PHARMA (UK) LTD · United Kingdom
$38K
2
DITA ESTFARM LLC · Moldova
$6K
3
SOVEREIGN SPEED FRA GMBH · Germany
$238.05
Top 1 dosage forms
1
Tablet
$50K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $38K | $38K |
| Nov | 5 | $12K | $2K |
| Dec | 0 | $0.0000 | — |
Shipment register · 6 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — TORRENT PHARMACEUTICALS LTD · 1 shipments · $38K | |||||||||||
| 1 | Oct 2025 | TORRENT PHARMA (UK) LTD | United Kingdom | Tablet | 200 | NOS | $190.04 | $38K | AHMEDABAD AIR | LONDON METROPOLITAN | AIR |
| SUPPLIER #2 — KWALITY PHARMACEUTICALS LTD · 2 shipments · $11K | |||||||||||
| 2 | Nov 2025 | DITA ESTFARM LLC | Moldova | Tablet | 25.8K | NOS | $0.222 | $6K | DELHI AIR | CHISINAU | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Moldova | Tablet | 25.8K | NOS | $0.222 | $6K | DELHI AIR | CHISINAU | AIR |
| SUPPLIER #3 — SACRED LEAVES PVT LTD · 3 shipments · $238.05 | |||||||||||
| 4 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Tablet | 10 | PCS | $0.0000 | $0.0000 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| 5 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Tablet | 10 | PCS | $0.0000 | $0.0000 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
| 6 | Nov 2025 | SOVEREIGN SPEED FRA GMBH | Germany | Tablet | 10 | PCS | $23.80 | $238.05 | DELHI AIR | FRANKFURT/MAIN INT'L | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
6 countries · 7 shipments · $279K · 6 Indian suppliers · 5 buyers
SHIPMENTS
7
USD
$279K
COUNTRIES
6
SUPPLIERS
6
BUYERS
5
HHI
9,809
concentrated
Top 6 destination countries in Americas
1
United States (99.0%)
$276K
2
Cuba (0.6%)
$2K
3
Mexico (0.2%)
$620.59
4
Venezuela (0.1%)
$398.79
5
Guyana (0.0%)
$81.59
6
Brazil (0.0%)
$0.508
Top 6 Indian suppliers into Americas
1
TORRENT PHARMACEUTICALS LTD
$276K
2
CRITICALKARE PHARMA
$2K
3
MYGENIC HEALTHCARE PVT LTD
$620.59
4
GALAXY SUPER SPECIALITY
$398.79
5
PHARMACO LIFESCIENCES
$81.59
6
HETERO LABS LTD
$0.508
Top 4 Americas importers
1
TORRENT PHARMA INC · United States
$276K
2
MEDICUBA, S.A · Cuba
$2K
3
LATOYA SHONELL GOODINGS · Guyana
$81.59
4
CAMBER FARMACEUTICA LTDA · Brazil
$0.508
Top 2 dosage forms
1
Tablet
$279K
2
Unknown
$0.169
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $276K | $92K |
| Nov | 2 | $1K | $509.69 |
| Dec | 2 | $2K | $833.40 |
Shipment register · 7 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — TORRENT PHARMACEUTICALS LTD · 1 shipments · $276K | |||||||||||
| 1 | Oct 2025 | TORRENT PHARMA INC | United States | Tablet | 210 | NOS | $1K | $276K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| SUPPLIER #2 — CRITICALKARE PHARMA · 1 shipments · $2K | |||||||||||
| 2 | Dec 2025 | MEDICUBA, S.A | Cuba | Tablet | 124 | NOS | $12.78 | $2K | MUMBAI AIR (SAHAR) | HAVANA | AIR |
| SUPPLIER #3 — MYGENIC HEALTHCARE PVT LTD · 1 shipments · $620.59 | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Mexico | Tablet | 15 | NOS | $41.37 | $620.59 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #4 — GALAXY SUPER SPECIALITY · 1 shipments · $398.79 | |||||||||||
| 4 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 10 | NOS | $39.88 | $398.79 | DELHI AIR | MADRID | AIR |
| SUPPLIER #5 — PHARMACO LIFESCIENCES · 1 shipments · $81.59 | |||||||||||
| 5 | Dec 2025 | LATOYA SHONELL GOODINGS | Guyana | Tablet | 4 | NOS | $20.40 | $81.59 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| SUPPLIER #6 — HETERO LABS LTD · 2 shipments · $0.508 | |||||||||||
| 6 | Oct 2025 | CAMBER FARMACEUTICA LTDA | Brazil | 1 | NOS | $0.169 | $0.169 | HYDERABAD AIR | Guarulhos | AIR | |
| 7 | Oct 2025 | CAMBER FARMACEUTICA LTDA | Brazil | Tablet | 2 | NOS | $0.169 | $0.339 | HYDERABAD AIR | Guarulhos | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 43 Indian sorafenib exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped sorafenib in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | AHMEDABAD. GUJARAT | 2 | $314K | Tablet | Americas, Europe |
| 2 | INDCHEMIE HEALTH SPECIALITIES PVT LTD | DAMAN | 3 | $122K | Capsule | Asia |
| 3 | FLORENCIA HEALTHCARE | NOIDA | 2 | $15K | Tablet | Asia |
| 4 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 2 | $11K | Tablet | Europe |
| 5 | KERK | DELHI | 1 | $9K | Tablet | Asia |
| 6 | WESTCOAST PHARMACEUTICAL WORKS LTD | AHMEDABAD | 1 | $8K | Gel | Asia |
| 7 | THERDOSE PHARMA PVT LTD | PRAGATHI NAGAR | 1 | $6K | Tablet | Africa |
| 8 | RESCUERS LIFE SCIENCES LTD | NALAGARH ROAD BADDI | 2 | $5K | Tablet | Asia |
| 9 | SANSKRUTI PHARMA | SURAT | 5 | $3K | Tablet | Africa |
| 10 | ILMIC HEALTH CARE PVT LTD | NEW DELHI | 3 | $3K | Tablet | Africa |
| 11 | KASO PHARMACEUTICALS | NEW DELHI | 1 | $3K | Tablet | Asia |
| 12 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 1 | $3K | Tablet | Africa |
| 13 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 2 | $3K | Tablet | Africa |
| 14 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 2 | $2K | Tablet | Africa |
| 15 | CRITICALKARE PHARMA | SURAT | 1 | $2K | Tablet | Americas |
| 16 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 3 | $2K | Tablet | Asia |
| 17 | SHOBHA MEDICINE | BHAGIRATH PALACE | 1 | $1K | Tablet | Asia |
| 18 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 3 | $913.58 | Tablet | Africa |
| 19 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 1 | $620.59 | Tablet | Americas |
| 20 | KHATU ENTERPRISES | NAGPUR | 1 | $564.46 | Tablet | Africa |
| 21 | BRUCK PHARMA PVT LTD | NANI | 2 | $490.84 | Tablet | Africa |
| 22 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 2 | $479.18 | Tablet | Africa |
| 23 | RUTVA MEDICARE | SURAT | 2 | $475.08 | Tablet | Africa |
| 24 | RMPL PHARMA LLP | MUMBAI | 2 | $444.23 | Tablet | Asia |
| 25 | ASPIRA BIOHEALTH LLP | SALEM | 1 | $429.51 | Tablet | Africa |
| 26 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $398.79 | Tablet | Americas |
| 27 | VATS INDUSTRIES PVT LTD | NEW DELHI | 1 | $322.89 | Tablet | Asia |
| 28 | ASPIDA LIFE SCIENCES PVT LTD | GHAZIABAD | 1 | $299.00 | Tablet | Africa |
| 29 | SACRED LEAVES PVT LTD | NEW DELHI | 3 | $238.05 | Tablet | Europe |
| 30 | HUMANKIND PHARMA | Mumbai | 7 | $227.92 | Tablet | Asia |
| 31 | MATHI ASSOCIATES | MUMBAI | 1 | $176.66 | Tablet | Africa |
| 32 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $174.10 | Tablet | Africa |
| 33 | J.A. UNITED EXPORTS PVT LTD | VASHI | 1 | $134.22 | Tablet | Asia |
| 34 | PHARMACO LIFESCIENCES | Nagpur | 1 | $81.59 | Tablet | Americas |
| 35 | SARTAJ PHARMA PVT LTD | CHANDNI CHOWK | 1 | $59.04 | Tablet | Asia |
| 36 | MACLEODS PHARMACEUTICALS LTD | MOUZA NEMAI MATIGARA PARGANA PATHAR | 1 | $55.13 | Tablet | Asia |
| 37 | MDS ENTERPRISES | MUMBAI | 4 | $15.95 | Tablet | Asia |
| 38 | SR FARMALIFE PVT LTD | MUMBAI | 1 | $11.37 | Tablet | Africa |
| 39 | BARAKAH BIOHEALTH LLP | Tiruppur | 2 | $4.74 | Tablet | Africa |
| 40 | M T MADON EXPORTS | MUMBAI | 1 | $4.60 | Tablet | Africa |
| 41 | GENETEC LIFESCIENCES | MUMBAI | 1 | $3.30 | Africa | |
| 42 | VAMA LIFECARE PVT LTD | MUMBAI | 2 | $1.44 | Tablet | Asia |
| 43 | HETERO LABS LTD | HYDERABAD | 2 | $0.508 | Tablet | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 27 global sorafenib importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian sorafenib in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | TORRENT PHARMA INC | United States | 1 | $276K | TORRENT PHARMACEUTIC… | Tablet |
| 2 | BALMED PHARMA PVT LTD | Nepal | 3 | $122K | INDCHEMIE HEALTH SPE… | Capsule |
| 3 | TORRENT PHARMA (UK) LTD | United Kingdom | 1 | $38K | TORRENT PHARMACEUTIC… | Tablet |
| 4 | MUBARAK HASHIMI LTD | Afghanistan | 1 | $9K | KERK | Tablet |
| 5 | SOZAHEALTH LTD | Mauritius | 1 | $6K | THERDOSE PHARMA PVT … | Tablet |
| 6 | DITA ESTFARM LLC | Moldova | 1 | $6K | KWALITY PHARMACEUTIC… | Tablet |
| 7 | ETEMED MOSLEH LTD | Afghanistan | 2 | $5K | RESCUERS LIFE SCIENC… | Tablet |
| 8 | EHSAN COMERCIO GERL LDA | Angola | 3 | $3K | ILMIC HEALTH CARE PV… | Tablet |
| 9 | NANG DAO | Laos | 1 | $3K | KASO PHARMACEUTICALS | Tablet |
| 10 | CENTRAIMED | Equatorial Guinea | 1 | $3K | PIRZE LIFECARE PVT LTD | Tablet |
| 11 | MEDICUBA, S.A | Cuba | 1 | $2K | CRITICALKARE PHARMA | Tablet |
| 12 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $2K | JMB PHARMACEUTICALS … | Tablet |
| 13 | DALIAN SA | China | 1 | $1K | SHOBHA MEDICINE | Tablet |
| 14 | OUMAR KONE | Mali | 1 | $564.46 | KHATU ENTERPRISES | Tablet |
| 15 | ATLAS TRADING COMPANY | Iraq | 1 | $322.89 | VATS INDUSTRIES PVT … | Tablet |
| 16 | GOLD TREE PHARMACEUTICALS LTD | Kenya | 1 | $299.00 | ASPIDA LIFE SCIENCES… | Tablet |
| 17 | SOVEREIGN SPEED FRA GMBH | Germany | 3 | $238.05 | SACRED LEAVES PVT LTD | Tablet |
| 18 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 7 | $227.92 | HUMANKIND PHARMA | Tablet |
| 19 | R PHARMA | Malawi | 1 | $176.66 | MATHI ASSOCIATES | Tablet |
| 20 | FREIGHTER MADE LOGISTICS LTD | Ghana | 1 | $174.10 | BAKER & DAVIS PVT LTD | Tablet |
| 21 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 1 | $134.22 | J.A. UNITED EXPORTS … | Tablet |
| 22 | LATOYA SHONELL GOODINGS | Guyana | 1 | $81.59 | PHARMACO LIFESCIENCES | Tablet |
| 23 | SARTAJ ENTERPRISES LTD | Afghanistan | 1 | $59.04 | SARTAJ PHARMA PVT LTD | Tablet |
| 24 | MEDINURA PVT LTD | Nepal | 1 | $55.13 | MACLEODS PHARMACEUTI… | Tablet |
| 25 | MOHAMED AHEMED MOHAMUD | Somalia | 1 | $4.60 | M T MADON EXPORTS | Tablet |
| 26 | AS PER INVOICE SRI LANKA | Sri Lanka | 2 | $1.44 | VAMA LIFECARE PVT LTD | Tablet |
| 27 | CAMBER FARMACEUTICA LTDA | Brazil | 2 | $0.508 | HETERO LABS LTD | Tablet |
This report covers 79 2025-Q4 Sorafenib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/sorafenib
Talk to our trade analyst
Need a custom sorafenib report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/sorafenib
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Sorafenib product page
Live data, supplier directory, price trends, and trade route analysis